Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagesh Kamath

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gastroenterology|June 29, 2014
Infliximab for moderate to severe ulcerative colitis: the jury isn't in yetNagesh Kamath, Asha Kamath, C Ganesh Pai
Indian Journal of Pharmacology|March 22, 2016
Pure red cell aplasia due to azathioprine therapy for Crohn's diseaseNagesh Kamath, C Ganesh Pai, Thylbert Deltombe
North American Journal of Medical Sciences|April 4, 2015
Hereditary hemorrhagic telangiectasiaNagesh Kamath, Sumit Bhatia, Harneet Singh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gastroenterology|June 29, 2014
Infliximab for moderate to severe ulcerative colitis: the jury isn't in yetNagesh Kamath, Asha Kamath, C Ganesh Pai
Indian Journal of Pharmacology|March 22, 2016
Pure red cell aplasia due to azathioprine therapy for Crohn's diseaseNagesh Kamath, C Ganesh Pai, Thylbert Deltombe
North American Journal of Medical Sciences|April 4, 2015
Hereditary hemorrhagic telangiectasiaNagesh Kamath, Sumit Bhatia, Harneet Singh, et al.
Pageof 1